Home / Drug shortages / Adalimumab-adaz Injection

Adalimumab-adaz Injection — FDA Drug Shortage

To Be Discontinued — Sandoz Inc.

The FDA lists a drug shortage record for Adalimumab-adaz Injection (injection) from Sandoz Inc. with status To Be Discontinued. The shortage was first posted on 01/13/2026.

Shortage Details

Status
To Be Discontinued
Company
Sandoz Inc.
Package NDC
61314-473-64
Dosage Form
Injection
Presentation
Hyrimoz, Injection, 40 mg/.4 mL (NDC 61314-473-64)
Initial Posting
01/13/2026
Revised Date

FDA data resources